Skip to main content
. 2021 Aug 10;9(8):990. doi: 10.3390/biomedicines9080990

Figure 9.

Figure 9

Histopathological assessment of heart sections in (A) HCT116 colon cancer cells implant and (B) MDA-MB-231-Luc breast cancer cells implant treated with costunolide (COS), doxorubicin (DOX), costunolide + doxorubicin (COS + DOX), costunolide-nanoparticles (COS-NPs), and costunolide-nanoparticles + doxorubicin (COS-NPs + DOX). Black arrows refer to cellular damages of doxorubicin (DOX). Scale bar shows magnification 40×.